ALAD and brain neoplasm: Given that the ALAD G177C polymorphism affects the toxicokinetics of lead in the body, and that exposure to lead may increase the risk of adult brain tumors, we postulated a possible association of ALAD G177C genotype and risk of intracranial tumors of the brain and nervous system (hereafter referred to as brain tumors).